BMRA Insider Trading Activity and SEC Form 4 Filings
BMRA insider trading summary
Over the past 12 months, insiders at Biomerica Inc (BMRA) reported 5 open-market purchases worth $158K by 5 insiders and no sales on SEC Form 4. Net insider buying was $158K.
Latest BMRA insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 26, 2026 | Allen Barbieri | Executive Vice Chairman | Buy | $32K (20,000 @ $1.60) |
| Aug 26, 2026 | David Moatazedi | Director | Buy | $16K (10,000 @ $1.60) |
| Aug 26, 2026 | Zackary S. Irani | Chief Executive Officer | Buy | $50K (31,250 @ $1.60) |
| Aug 26, 2026 | Eric Chin | Director | Buy | $10K (6,250 @ $1.60) |
| Aug 20, 2026 | M. Huff Gary | Director | Buy | $50K (31,250 @ $1.60) |
| May 25, 2023 | Zackary S. Irani | Chief Executive Officer | Buy | $310 (200 @ $1.55) |
| May 24, 2023 | Zackary S. Irani | Chief Executive Officer | Buy | $805 (500 @ $1.61) |
| May 12, 2023 | Zackary S. Irani | Chief Executive Officer | Buy | $2K (1,700 @ $1.17) |
| May 10, 2023 | Zackary S. Irani | Chief Executive Officer | Buy | $635 (500 @ $1.27) |
| May 9, 2023 | Zackary S. Irani | Chief Executive Officer | Buy | $417 (300 @ $1.39) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.